MedPath

Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain

Not Applicable
Active, not recruiting
Conditions
Musculoskeletal Pain
Fibromyalgia
Chronic Pain
Virtual Reality
Interventions
Behavioral: Pain Rehabilitation Virtual Reality (PRVR)
Registration Number
NCT04636177
Lead Sponsor
Stanford University
Brief Summary

The proposed research is a single arm feasibility trial of pain rehabilitation virtual reality (PRVR) aimed at measuring feasibility, acceptability and utility of VR as well as changes in physical function and fear for adolescents with chronic musculoskeletal pain. The intervention includes standard physiotherapy treatment including functional goal setting and progressive exercise.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  • 10 to 17 years old
  • Musculoskeletal pain (e.g. localized [back, limb], diffuse) not due to acute trauma (e.g. active sprain or fracture)
  • English Language Proficiency
Read More
Exclusion Criteria
  • Significant cognitive impairment (e.g., brain injury)
  • Significant medical or psychiatric problem that would interfere (e.g. psychosis, suicidality)
  • Presents with a condition that interferes with virtual reality usage (e.g., history of seizure, facial injury precluding safe placement of headset, visual impairment, significant hearing impairment impact ability to follow audio instructions).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pain Rehabilitation Virtual Reality (PRVR)Pain Rehabilitation Virtual Reality (PRVR)Participants will complete VR in PT to engage participants in a series of immersive games customized to align with individual PT needs delivered over \~6-12 weeks or until clinician believes the patient is done with treatment. Patients in the PRVR arm will be given a structured HEP to practice prescribed exercises at home with integrated VR activities. PRVR participants will be allocated a VR headset for use in PT sessions and with HEP. VR will supplement treatment and be used in session (either in-person or telehealth) and at home as part of their prescribed treatment homework.
Primary Outcome Measures
NameTimeMethod
Feasibility, Acceptability, and Utility of VRBaseline to end of treatment at 6-8 weeks, on average

Acceptability will be assessed via collected use metrics (e.g. how long the app was played each day) and will also qualitatively at the end of treatment through interview questions related to acceptability, ease of use, comprehensibility, and suggestions for improvement. Qualitative responses will be described and summarized.

Secondary Outcome Measures
NameTimeMethod
Physical Function: Upper ExtremityBaseline to end of treatment at 6-8 weeks, on average

Upper Extremity Functional Index (UEFI): a 20- item validated patient-reported measures of

Pain-related Fear and AvoidanceBaseline to end of treatment at 6-8 weeks, on average

Fear of Pain Questionnaire Short Form (FOPQ- SF): a 10-item validated patient-reported measure of pain-related fear and avoidance. (score Min=0, Max=40; lower score indicates less fear and avoidance/better outcomes).

Physical Function: Lower ExtremityBaseline to end of treatment at 6-8 weeks, on average

Lower Extremity Functional Scale (LEFS): a 20-item validated patient-reported measure of lower extremity function. (score Min=0, Max=80; lower score indicates greater disability/worse outcomes).

Trial Locations

Locations (2)

California Rehabilitation and Sports Therapy

🇺🇸

Palo Alto, California, United States

Pediatric Pain Management Clinic - Stanford Children's Health

🇺🇸

Menlo Park, California, United States

© Copyright 2025. All Rights Reserved by MedPath